Quiz
A 61-year-old male patient without any unusual symptoms underwent a colonoscopy as part of a routine health examination. During the procedure, an 8-mm, smoothly elevated lesion was identified in the distal rectum, approximately 2 cm above the anal verge. The lesion was initially suspected to be a subepithelial tumor (SET), and the patient was referred to the gastroenterology department of our institution for further evaluation. The patient was in good general condition. Laboratory testing, including tumor markers, revealed values within normal limits: carcinoembryonic antigen 2.1 ng/mL, carbohydrate antigen 19-9 15.70 U/mL, and prostate-specific antigen 0.006 ng/mL. He denied any significant past medical or surgical history, and no relevant familial predisposition to malignancy was noted.
Colonoscopy at our institution confirmed a smoothly elevated lesion located approximately 2 cm above the anal verge (Fig. 1). To further characterize the lesion, endoscopic ultrasound was performed, which demonstrated a well-circumscribed hypoechoic mass confined to the second and third layers of the rectal wall. There was no evidence of perirectal or regional lymph node enlargement (Fig. 2). En bloc resection was subsequently performed via endoscopic mucosal resection with a ligation device (Fig. 3). Based on these findings, what is the most likely diagnosis?
Answer
Histopathologic examination of the resected specimen revealed a moderately differentiated adenocarcinoma measuring 0.8×0.4 cm, classified as pT1 with submucosal invasion of 1,900 μm out of a total submucosal thickness of 2,000 μm (Fig. 4). Notably, no additional high-risk histological features, such as lymphovascular invasion or tumor budding, were identified. After a comprehensive discussion with the patient regarding the risks and benefits of surgery, a decision was made to proceed with conservative management and close surveillance rather than additional surgical intervention. He has remained recurrence-free over a 4-year follow-up period.
Most SETs originate from the submucosal or muscularis propria layers of the gastrointestinal tract, whereas epithelial cell-derived malignancies, such as adenocarcinomas, originate from the mucosal epithelium.1 This distinct origin typically results in differing endoscopic appearances: SETs usually present as smooth, elevated lesions with intact overlying mucosa, whereas epithelial cell-derived malignancies often exhibit mucosal surface abnormalities such as erosion, ulceration, or friability.2,3 Consequently, mucosal patterns on endoscopy are key to differentiating true SETs from epithelial cell-derived malignancies.
However, rare cases of gastrointestinal adenocarcinomas that are entirely covered with a normal-appearing mucosa have been reported. To date, fewer than 10 cases of rectal adenocarcinoma completely covered by normal mucosa have been reported.4-6 Similar cases have also been described in the esophagus and stomach.7,8 Although the mechanism remains unclear, some hypotheses include vertical infiltration patterns, ectopic glandular origin, or growth along submucosal lymphovascular channels.9 Previous studies have shown that such tumors are often characterized by small size, poorly differentiated or mucinous histology, and a higher incidence of lymphovascular invasion and early metastasis. These features suggest that, despite their benign endoscopic appearance, these lesions may exhibit aggressive biological behavior.
In the present case, rectal adenocarcinoma was histologically confirmed from a lesion initially presumed to be a SET. This highlights that even small, smooth, and mucosa-covered lesions in the rectum may harbor malignancy. Therefore, if SETs with normal overlying mucosa are identified in the rectum, underlying adenocarcinoma must always be considered. Furthermore, given the potential for various malignancies arise as rectal SETs, complete endoscopic resection is mandatory.
Conflicts of Interest
The authors have no potential conflicts of interest.
Funding
This work was supported by a clinical research grant from the Pusan National University Hospital in 2026.
Author Contributions
Conceptualization: DHB; Data curation: all authors; Formal analysis: all authors; Investigation: all authors; Methodology: all authors; Supervision: DHB; Writing–original draft: YBP; Writing–review & editing: all authors.
Fig. 1.Endoscopic appearance of a subepithelial rectal lesion. (A, B) Conventional white-light endoscopy reveals a small, smooth-surfaced elevated lesion located 2 cm above the anal verge. The overlying mucosa appears intact without erythema, erosion, or ulceration. (C) Narrow-band imaging with near focus shows a regular surface pattern and capillary network, with no evidence of pit pattern irregularity or microvascular distortion.
Fig. 2.Endoscopic ultrasonographic (EUS) findings of the rectal lesion. (A) EUS using a mini-probe shows a well-demarcated, homogeneous hypoechoic lesion confined to the second and third layers of the rectal wall. (B) The lesion measures approximately 0.8 cm in maximal diameter on EUS.
Fig. 3.Endoscopic mucosal resection (EMR-L) procedure and resected specimen. (A) The lesion is captured and lifted using a band ligation device (EMR-L) following submucosal injection. (B) Post-resection ulcer base following en bloc removal of the lesion. The resection site shows a clean mucosal defect with coagulated margins and no immediate signs of perforation or bleeding. (C) Gross view of the resected specimen.
Fig. 4.Histopathologic findings of the resected rectal lesion. (A) Low-power view of the endoscopic mucosal resection specimen shows a moderately differentiated adenocarcinoma infiltrating the submucosal layer. The vertical resection margin is clear (hematoxylin and eosin [H&E] stain, ×40). (B) High-power view (H&E stain, ×100) highlights irregular glandular structures composed of atypical epithelial cells, consistent with moderately differentiated adenocarcinoma.
REFERENCES
- 1. Hong SM, Baek DH. Endoscopic treatment for rectal neuroendocrine tumor: which method is better? Clin Endosc 2022;55:496–506.ArticlePubMedPMCPDF
- 2. Choi J, Kim SG, Im JP, et al. Endoscopic prediction of tumor invasion depth in early gastric cancer. Gastrointest Endosc 2011;73:917–927.ArticlePubMed
- 3. Nishida T, Kawai N, Yamaguchi S, et al. Submucosal tumors: comprehensive guide for the diagnosis and therapy of gastrointestinal submucosal tumors. Dig Endosc 2013;25:479–489.ArticlePubMed
- 4. Sato K, Kojima Y, Matsuno Y, et al. A case of mucoid carcinoma of the sigmoid colon with features of a submucosal tumor. Nihon Shokakibyo Gakkai Zasshi 2011;108:88–94.PubMed
- 5. Shiraiwa S, Taniwaki S, Imamura T, et al. A case of rectal cancer presented as submucosal tumor without the continuation with the mucous membrane. Jpn J Gastroenterol 2014;75:749–753.Article
- 6. Tanio A, Saito H, Ashida K, et al. Resection of rectal cancer resembling submucosal tumor that was preoperatively diagnosed with endoscopic ultrasound-guided biopsy. Surg Case Rep 2017;3:84.ArticlePubMedPMCPDF
- 7. Kishino T, Yamaguchi Y, Yamagishi T, et al. Submucosal tumor (SMT)-like esophageal squamous cell carcinoma with gastric metastasis. Hepatogastroenterology 2000;47:1581–1584.PubMed
- 8. Ohara N, Tominaga O, Uchiyama M, et al. A case of advanced gastric cancer resembling submucosal tumor of the stomach. Jpn J Clin Oncol 1997;27:423–426.ArticlePubMed
- 9. Nakajima T, Kamano T, Shibasaki K, et al. Colonic carcinoma resembling submucosal tumor: report of a case and review of the literature. Int J Gastrointest Cancer 2005;36:155–161.ArticlePubMed
Citations
Citations to this article as recorded by
